SCHEMBL8287231

SCHEMBL8287231

O=c1cc(Nc2ccccc2)n(-c2ccccc2)c2nc(S(=O)(=O)c3ccccc3)cc(C(F)(F)F)c12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.64
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
WEE1 P30291 1/20 0.34
CYP1A2 P05177 1/20 0.34
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
CDK1 P06493 1/20 0.33
CDK2 P24941 1/20 0.33
KDR P35968 1/20 0.33
PTK2 Q05397 1/20 0.33
HTR6 P50406 1/20 0.33
TP53 P04637 1/20 0.32
CDK4 P11802 1/20 0.32
CCND1 P24385 1/20 0.32
CCND2 P30279 1/20 0.32
CCND3 P30281 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8360285 0.86 PDE11A (0.59) PDE11AMEN1KMT2AMAPTLMNA
SCHEMBL8285146 0.84 PDE11A (0.56) PDE11AMEN1KMT2AMAPTLMNA
SCHEMBL5871948 0.83 PDE11A (0.56) PDE11AMEN1KMT2AMAPTLMNA
SCHEMBL6879695 0.82 PDE11A (0.66) PDE11AMEN1KMT2AMAPTLMNA
SCHEMBL5872038 0.82 PDE11A (0.66) PDE11AMEN1KMT2AMAPTLMNA
SCHEMBL6879687 0.82 PDE11A (0.66) PDE11AMEN1KMT2AMAPTLMNA
SCHEMBL5871860 0.81 PDE11A (0.65) PDE11AMEN1KMT2AMAPTLMNA
SCHEMBL5871369 0.81 PDE11A (0.82) PDE11AMEN1KMT2AMAPTLMNA
SCHEMBL5872148 0.81 PDE11A (0.60) PDE11AMEN1KMT2AMAPTLMNA
SCHEMBL8285196 0.81 PDE11A (0.64) PDE11AMEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed